Segui
Vasily Ogryzko
Vasily Ogryzko
INSERM, Institute Gustave Roussy, CNRS UMR 816, University Paris XI
Email verificata su gustaveroussy.fr
Titolo
Citata da
Citata da
Anno
The transcriptional coactivators p300 and CBP are histone acetyltransferases
VV Ogryzko, RL Schiltz, V Russanova, BH Howard, Y Nakatani
Cell 87 (5), 953-959, 1996
37241996
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
XJ Yang, VV Ogryzko, J Nishikawa, BH Howard, Y Nakatani
Nature Publishing Group 382 (6589), 319-324, 1996
19391996
Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
T Ikura, VV Ogryzko, M Grigoriev, R Groisman, J Wang, M Horikoshi, ...
Cell 102 (4), 463-473, 2000
12402000
Recruitment of p300/CBP in p53-dependent signal pathways
ML Avantaggiati, V Ogryzko, K Gardner, A Giordano, AS Levine, K Kelly
Cell 89 (7), 1175-1184, 1997
9321997
Regulation of activity of the transcription factor GATA-1 by acetylation
J Boyes, P Byfield, Y Nakatani, V Ogryzko
Nature 396 (6711), 594-598, 1998
9231998
Acetylation of general transcription factors by histone acetyltransferases
A Imhof, XJ Yang, VV Ogryzko, Y Nakatani, AP Wolffe, H Ge
Current Biology 7 (9), 689-692, 1997
8071997
Histone-like TAFs within the PCAF histone acetylase complex
VV Ogryzko, T Kotani, X Zhang, RL Schiltz, T Howard, XJ Yang, ...
Cell 94 (1), 35-44, 1998
6821998
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation
PL Puri, V Sartorelli, XJ Yang, Y Hamamori, VV Ogryzko, BH Howard, ...
Molecular cell 1 (1), 35-45, 1997
5161997
Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
Y Hamamori, V Sartorelli, V Ogryzko, PL Puri, HY Wu, JYJ Wang, ...
Cell 96 (3), 405-413, 1999
4901999
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation
M Fu, C Wang, AT Reutens, J Wang, RH Angeletti, L Siconolfi-Baez, ...
Journal of Biological Chemistry 275 (27), 20853-20860, 2000
4782000
Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
V Sartorelli, PL Puri, Y Hamamori, V Ogryzko, G Chung, Y Nakatani, ...
Molecular cell 4 (5), 725-734, 1999
4471999
A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
D Chakravarti, V Ogryzko, HY Kao, A Nash, H Chen, Y Nakatani, ...
Cell 96 (3), 393-403, 1999
4251999
A human RNA polymerase II complex containing factors that modify chromatin structure
H Cho, G Orphanides, X Sun, XJ Yang, V Ogryzko, E Lees, Y Nakatani, ...
Molecular and cellular biology 18 (9), 5355-5363, 1998
3961998
The p400 complex is an essential E1A transformation target
M Fuchs, J Gerber, R Drapkin, S Sif, T Ikura, V Ogryzko, WS Lane, ...
Cell 106 (3), 297-307, 2001
3862001
Activation of integrated provirus requires histone acetyltransferase p300 and P/CAF are coactivators for HIV-1 Tat
M Benkirane, RF Chun, H Xiao, VV Ogryzko, BH Howard, Y Nakatani, ...
Journal of Biological Chemistry 273 (38), 24898-24905, 1998
3641998
The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation
G Caretti, RL Schiltz, FJ Dilworth, M Di Padova, P Zhao, V Ogryzko, ...
Developmental cell 11 (4), 547-560, 2006
3442006
Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.
VV Ogryzko, TH Hirai, VR Russanova, DA Barbie, BH Howard
Molecular and cellular biology 16 (9), 5210-5218, 1996
3381996
Section III-Polymerase Associated Factors-37 Immunoaffinity Purification of Mammalian Protein Complexes
Y Nakatani, V Ogryzko
Methods in Enzymology 370, 430-444, 2003
2952003
Immunoaffinity purification of mammalian protein complexes
Y Nakatani, V Ogryzko
Methods in enzymology, 430-444, 2003
2952003
WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases.
VV Ogryzko, P Wong, BH Howard
Molecular and cellular biology 17 (8), 4877-4882, 1997
2611997
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20